18 Panel Test Cup with Xylazine & Kratom

18 Panel Test Cup with Xylazine & Kratom

The 18 panel test cup combines urine specimen collection and preliminary screening for 18 drugs, drug classes and metabolites in one integrated Serenity 120 mL device. This configuration is distinguished by dedicated XYL/1000 xylazine and KRA/500 kratom panels together with fentanyl, EtG, ketamine and tramadol screening.

The cup also includes commonly requested screening targets such as amphetamines, barbiturates, buprenorphine, benzodiazepines, cocaine, MDMA, methamphetamine, methadone, opiates, oxycodone, PCP and THC. Each target is represented by its own screening panel and should be interpreted independently according to the manufacturer’s instructions.

Xylazine is one of the primary reasons to choose this configuration. A standard opiate or fentanyl panel does not indicate that xylazine screening is included. This product contains a dedicated XYL/1000 assay specifically listed as part of its 18-panel configuration.

The KRA/500 panel adds kratom-related screening, while FEN/20, ETG/300, KET/1000 and TRA/100 provide additional specialty coverage. These targets make this configuration substantially different from other 18-panel products that instead include gabapentin, K2, TCA, dual THC cutoffs or specimen-validity indicators.

This product contains one THC/50 panel and does not include TCA or pH, specific gravity and creatinine ADLTX indicators. Buyers should therefore compare the complete analyte list rather than selecting an 18 panel drug test cup based only on its panel count.

The product is labeled Forensic Use Only. Buyers requiring another configuration can compare the complete selection of 18 panel drug test cups.

18 Panel Test Cup List and Cutoff Levels

The complete screening configuration is shown below. All 18 listed targets are separate preliminary screening panels.

The presence of XYL/1000, KRA/500, FEN/20, ETG/300, KET/1000 and TRA/100 is the primary specialty-panel combination for this product.

FEN/20 is separate from OPI/300, and TRA/100 is a dedicated tramadol panel. Likewise, the XYL/1000 panel should not be inferred from the presence of fentanyl, opiates or any other drug class.

Xylazine, Kratom and Specialty Screening in One Cup

This configuration combines six specialty panels with twelve additional screening targets. Buyers should check the complete list when selecting a cup or arranging a repeat order.

Xylazine: The XYL panel provides dedicated preliminary urine screening for xylazine. Its inclusion should be verified separately when comparing products because the presence of an opiate or fentanyl panel does not establish that a cup includes XYL.

KRA/500 provides kratom-related screening. KRA should not automatically be described as a dedicated 7-hydroxymitragynine test unless the applicable manufacturer documentation identifies 7-OH as the target analyte. Buyers can review our 7-OH kratom testing guide for more information.

Fentanyl: The fentanyl assay is separate from the opiate, oxycodone, methadone and buprenorphine panels. Personnel should review and record the result for each applicable assay.

EtG: The ethyl glucuronide panel screens for an alcohol-related metabolite in urine. It does not provide a blood alcohol concentration or establish current impairment.

Ketamine and tramadol: Separate KET and TRA panels are included for programs requiring these targets. Their results should be recorded independently from the other screening panels.

The combination of XYL, KRA, FEN, EtG, KET and TRA identifies this particular cup. Other 18 panel products may contain a different selection of assays.

Serenity 120 mL Test Cup Features

The Serenity 120 mL format combines specimen collection and multi-panel screening in one device. Urine is collected directly into the cup, helping reduce specimen transfer during the initial screening process.

All 18 screening panels are incorporated into the device and can be reviewed after the appropriate development period. A built-in temperature strip provides an additional specimen-temperature reference shortly after collection when checked according to the manufacturer’s instructions.

This configuration does not list integrated pH, specific gravity or creatinine checks. Buyers specifically requiring ADLTX specimen-validity indicators should choose one of the 18 panel configurations that explicitly includes those features.

How to Use and Read Results

Always follow the package insert supplied with the exact product lot because collection requirements, activation procedures and interpretation windows can vary by device.

1. Confirm the product configuration, package condition and expiration date before use.
2. Collect urine directly into the cup to the specimen level specified in the manufacturer’s instructions and secure the lid.
3. Check the integrated temperature strip within the specified time period after collection.
4. Activate or expose the screening panels as directed and begin timing immediately.
5. Read and document all 18 panels within the manufacturer’s stated interpretation window.

• Negative: the required control line and test line appear for the applicable panel. A faint test line should be interpreted according to the manufacturer’s instructions.
• Preliminary Positive / Non-Negative: the control line appears but the corresponding test line is absent. The result is preliminary and may require laboratory confirmation.
• Invalid: the required control line does not appear. Do not interpret the affected panel and repeat testing according to the product instructions.

A screening cutoff does not determine dosage, impairment or the exact time of exposure. When a definitive analytical result is required, use the appropriate confirmatory laboratory procedure.

Forensic Use Only

This 18 panel test cup is labeled Forensic Use Only. It should be selected and used according to the current product labeling, package insert and requirements of the applicable forensic testing program.

Forensic Use Only status is not interchangeable with CLIA-waived status. Products with the same panel count may carry different intended-use designations.

For more information, review our Forensic Use Only drug testing guidance.

Detection Windows and Test Limitations

A screening cutoff does not establish a fixed detection window. Results can vary with the substance, timing and pattern of exposure, specimen concentration, assay cutoff and testing method.

A negative result does not exclude every possible exposure. The substance may be below the screening threshold, outside the assay’s detection capability or absent from the selected configuration.

Urine screening cannot determine impairment, dosage or the exact time of use. Unexpected findings and results affecting significant decisions require appropriate evaluation and confirmation. ARUP Consult’s drug testing guidance explains these limitations and the role of definitive testing.

This device is designed to screen urine specimens. It should not be used to test powders, pills or other substances directly.

Bulk 18 panel drug test with Kratom, Xylazine Drug Test Cups

DrugTestingCup.com offers quantity pricing for this xylazine and kratom configuration. Buyers can select the available order quantities on this page or request assistance with larger purchasing requirements.

For repeat orders, identify the product by SKU SM-CDOA-5185-FUO and confirm the required XYL, KRA, FEN, EtG, KET and TRA panels. This helps purchasing teams distinguish it from other 18 panel cups with different specialty assays.

Free shipping is available on qualifying orders of 100 or more cups, with same-day shipping on qualifying orders placed before 3 PM EST.

For purchasing guidance, review our bulk drug test cup buying guide. Organizations arranging larger orders can contact DrugTestingCup.com for assistance.

Frequently Asked Questions

What does this 18 panel test cup screen for?

This configuration includes AMP/1000, BAR/300, BUP/10, BZO/300, COC/300, MDMA/500, MET/1000, MTD/300, OPI/300, OXY/100, PCP/25, THC/50, TRA/100, KET/1000, FEN/20, ETG/300, KRA/500 and XYL/1000.

Does this 18 panel test cup include xylazine?

Yes. It includes a dedicated XYL/1000 xylazine screening panel.

Does this cup include kratom?

Yes. The configuration includes a KRA/500 kratom-related screening panel.

Is KRA/500 the same as a dedicated 7-OH test?

Not necessarily. Buyers specifically requiring 7-hydroxymitragynine screening should verify the target analyte identified in the applicable manufacturer’s documentation.

Does this test include fentanyl?

Yes. It includes a dedicated FEN/20 fentanyl screening panel separately from the OPI/300 opiate panel.

Does this 18 panel test include EtG?

Yes. ETG/300 is included for preliminary screening of ethyl glucuronide, an alcohol metabolite.

Does this test include ketamine?

Yes. It contains a dedicated KET/1000 ketamine screening panel.

Does it include tramadol?

Yes. The configuration includes TRA/100 as a dedicated tramadol screening panel.

Does this configuration include TCA or ADLTX?

No. This specific configuration does not list TCA or pH, specific gravity and creatinine specimen-validity indicators.

Is this 18 panel test cup CLIA waived?

No. This specific Serenity configuration is labeled Forensic Use Only.

Can this 18 panel test cup be purchased in bulk?

Yes. Quantity pricing is available, qualifying orders of 100 cups or more receive free shipping, and larger recurring or distributor orders may qualify for additional wholesale pricing.